The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis of efficacy and safety of fruquintinib plus paclitaxel versus paclitaxel in gastroesophageal junction adenocarcinoma patients from FRUTIGA: A randomized phase 3 clinical trial in second-line treatment of gastric/gastroesophageal junction adenocarcinoma.
 
Tianshu Liu
No Relationships to Disclose
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical
 
Feng Wang
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Weijian Guo
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Fuyou Zhao
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Kangsheng Gu
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Panfeng Tan
Employment - HUTCHMED
Stock and Other Ownership Interests - HUTCHMED
 
Michael Shi
Employment - HUTCHMED
Leadership - HUTCHMED
Stock and Other Ownership Interests - HUTCHMED